Fact CheckerSign in

NCT07566221Not yet recruiting

Increasing Lung Cancer Screening Among Emergency Department Patients - LCS R01

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients - LCS R01

Source: ClinicalTrials.gov · Last updated 5 May 2026

Brief summary (registry, in English)

This randomized clinical trial evaluates the effectiveness of text messaging and facilitated referral strategies to increase lung cancer screening uptake among emergency department patients who meet lung cancer screening eligibility criteria.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
1036 (estimated)
First submitted
27 Apr 2026
Start date
Mar 2027
Primary completion date
Dec 2030
Lead sponsor
University of Rochester
Diseases
Lung cancer
NCT number
NCT07566221

What you commit to

  • Study type: Interventional
  • Planned participants: 1036
  • From Mar 2027 to the primary completion date, Dec 2030
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Non-English/Spanish
  • Inability to provide consent (e.g. high clinical acuity, cognitive deficit)
  • Lack of text-capable mobile phone and/or inability to use text function

Who the study is looking for

  • Age 50 - 80
  • ≥ 20 pack-year smoking history
  • current smoker or quit within 15 years
  • English/Spanish speaking
  • Registered in the Emergency Department as a patient

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.